Literature DB >> 19233110

Genetics and embryological mechanisms of congenital heart diseases.

Fanny Bajolle1, Stéphane Zaffran, Damien Bonnet.   

Abstract

Developmental genetics of congenital heart diseases has evolved from analysis of embryo sections towards molecular genetics of cardiac morphogenesis with a dynamic view of cardiac development. Lineage analysis, transgenic animal models and retrospective clonal analysis of the developing heart led to identification of different cardiac lineages and their respective roles. Genetics of congenital heart diseases has also changed from formal genetic analysis of familial recurrences or population based analysis to screening for mutations in candidates genes identified in animal models. Based on these new concepts, genetic counselling in congenital heart diseases is based on the mechanism of a given heart defect rather than on its anatomy. Using this approach, genetic heterogeneity or intrafamilial variability of a molecular anomaly can at least be partially explained. Close cooperation between molecular embryologists, pathologists involved in heart development and paediatric cardiologists is crucial for further increase of knowledge in the field of cardiac morphogenesis and genetics of cardiac defects.

Entities:  

Mesh:

Year:  2008        PMID: 19233110     DOI: 10.1016/j.acvd.2008.06.020

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  9 in total

1.  ISL1 common variant rs1017 is not associated with susceptibility to congenital heart disease in a Chinese population.

Authors:  Lei Xue; Xiaowei Wang; Jing Xu; Xiaohan Xu; Xiang Liu; Zhibin Hu; Hongbing Shen; Yijiang Chen
Journal:  Genet Test Mol Biomarkers       Date:  2012-04-05

2.  Analysis of HOXB1 gene in a cohort of patients with sporadic ventricular septal defect.

Authors:  Amélie Pinard; Nathalie Eudes; Julia Mitchell; Fanny Bajolle; Maude Grelet; Joséphine Okoronkwo; Damien Bonnet; Gwenaelle Collod-Béroud; Stéphane Zaffran
Journal:  Mol Biol Rep       Date:  2018-06-19       Impact factor: 2.316

Review 3.  Epigenetics and Congenital Heart Diseases.

Authors:  Léa Linglart; Damien Bonnet
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-09

4.  Natural cardiogenesis-based template predicts cardiogenic potential of induced pluripotent stem cell lines.

Authors:  Almudena Martinez-Fernandez; Xing Li; Katherine A Hartjes; Andre Terzic; Timothy J Nelson
Journal:  Circ Cardiovasc Genet       Date:  2013-09-14

Review 5.  Tissue engineering: Relevance to neonatal congenital heart disease.

Authors:  Kevin M Blum; Gabriel J M Mirhaidari; Christopher K Breuer
Journal:  Semin Fetal Neonatal Med       Date:  2021-02-27       Impact factor: 3.726

6.  Effect of miR-20b on Apoptosis, Differentiation, the BMP Signaling Pathway and Mitochondrial Function in the P19 Cell Model of Cardiac Differentiation In Vitro.

Authors:  Shasha Zhu; Xiaoshan Hu; Zhangbin Yu; Yuzhu Peng; Jingai Zhu; Xuehua Liu; Mengmeng Li; Shuping Han; Chun Zhu
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

Review 7.  The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?

Authors:  Aizati N A Daud; Jorieke E H Bergman; Wilhelmina S Kerstjens-Frederikse; Henk Groen; Bob Wilffert
Journal:  Int J Mol Sci       Date:  2016-08-13       Impact factor: 5.923

8.  miR-20a regulates proliferation, differentiation and apoptosis in P19 cell model of cardiac differentiation by targeting Smoothened.

Authors:  Feng Ai; Yanwei Zhang; Bangtian Peng
Journal:  Biol Open       Date:  2016-09-15       Impact factor: 2.422

9.  Knockdown of lincRNA PADNA promotes bupivacaine-induced neurotoxicity by miR-194/FBXW7 axis.

Authors:  Fan Yuning; Chen Liang; Wang Tenghuan; Nan Zhenhua; Gong Shengkai
Journal:  Mol Med       Date:  2020-08-13       Impact factor: 6.354

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.